Ticker
NXEN
Analysis
Nexien Biopharma, Inc. (NXEN) Stock Analysis
Nexien Biopharma, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to NXEN.
Nexien Biopharma, Inc.
Nexien Biopharma, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to NXEN.
Stock profile
Asset type
Stock
Market cap
$7,077
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
USD
Ticker listings
Nexien Biopharma, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- NXEN primary listing
Latest Nexien Biopharma, Inc. news
Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services.
Nexien BioPharma, Inc. Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic D...
Nexien BioPharma, Inc. Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic Dystrophies Types 1 and 2.
Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes f...
Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carb...
Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd
Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd.
Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office
Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office.
Research sections
Valuation
Review valuation context for Nexien Biopharma, Inc..
Future growth
Review future growth context for Nexien Biopharma, Inc..
Past performance
Review past performance context for Nexien Biopharma, Inc..
Financial health
Review financial health context for Nexien Biopharma, Inc..
Dividend
Review dividend context for Nexien Biopharma, Inc..
Management
Review management context for Nexien Biopharma, Inc..
Ownership
Review ownership context for Nexien Biopharma, Inc..
Other information
Review other information context for Nexien Biopharma, Inc..
Community
Review community context for Nexien Biopharma, Inc..